Canvas Wealth Advisors LLC decreased its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 17.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 268,037 shares of the medical instruments supplier's stock after selling 58,261 shares during the quarter. DENTSPLY SIRONA makes up approximately 1.0% of Canvas Wealth Advisors LLC's portfolio, making the stock its 25th largest position. Canvas Wealth Advisors LLC owned about 0.13% of DENTSPLY SIRONA worth $4,004,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Riverview Trust Co purchased a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at $26,000. Colonial Trust Co SC purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter worth about $26,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in DENTSPLY SIRONA by 700.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after buying an additional 1,568 shares during the period. True Wealth Design LLC increased its holdings in DENTSPLY SIRONA by 866.7% during the fourth quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock worth $41,000 after buying an additional 1,950 shares during the last quarter. Finally, Quarry LP raised its position in DENTSPLY SIRONA by 25.7% in the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after acquiring an additional 780 shares during the period. Hedge funds and other institutional investors own 95.70% of the company's stock.
Analyst Ratings Changes
A number of research analysts have recently weighed in on the stock. Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. UBS Group decreased their target price on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Barrington Research boosted their target price on DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a research note on Monday, May 12th. Mizuho cut their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Thursday, March 13th. Finally, Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $20.36.
Check Out Our Latest Stock Analysis on DENTSPLY SIRONA
DENTSPLY SIRONA Price Performance
NASDAQ:XRAY traded down $0.04 during mid-day trading on Monday, hitting $15.89. 1,221,294 shares of the stock traded hands, compared to its average volume of 2,937,251. The business's 50-day moving average price is $15.39 and its 200 day moving average price is $16.55. The company has a quick ratio of 0.76, a current ratio of 1.10 and a debt-to-equity ratio of 0.79. The company has a market cap of $3.17 billion, a PE ratio of -3.50, a price-to-earnings-growth ratio of 1.14 and a beta of 0.95. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $27.95.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping the consensus estimate of $0.29 by $0.14. The company had revenue of $879.00 million during the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 14.31% and a negative net margin of 24.42%. DENTSPLY SIRONA's revenue was down 7.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.42 earnings per share. On average, analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.
DENTSPLY SIRONA Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.03%. The ex-dividend date is Friday, June 27th. DENTSPLY SIRONA's payout ratio is currently -14.10%.
DENTSPLY SIRONA Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Read More

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.